IAM retention and blood brain barrier penetration

European Journal of Medicinal Chemistry

Volumn 33, Issue 3, 1998, Pages 215-223

  Ducarme, André ^a   Neuwels, Michel ^a   Goldstein, Solo ^a   Massingham, Roy ^a  

^a UCB PHARMA   (Belgium)

Author keywords

1,3,5 triazines; Blood brain barrier (BBB); High performance liquid chromatography (HPLC); Immobilized artificial membranes (IAM); Lipophilicity

Indexed keywords

BRONCHODILATING AGENT; OXOTREMORINE; TRIAZINE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL MEMBRANE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG DESIGN; DRUG PENETRATION; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0032033427     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(98)80011-1     Document Type: Article

References (18)

1. [1] Seiler P., Eur. J. Med. Chem. 9 (1974) 473-479.
2. [2] Young R.C., Mitchell R.C., Brown T.H., Ganellin C.R., Griffith R., Jones M., Rana K.K., Saunders D., Smith I.R., Sore N.E., Wilks T.J., J. Med. Chem. 31 (1988) 656-671.
3. [3] Tsai R.S., Thèse de doctorat présentée à la Faculté des Sciences de l'Université de Lausanne, Suisse, 1992.
4. [4] Hillgren K.M., Kato A., Borchardt R.T., Med. Res. Rev. 15(2) (1995) 83-109.
5. [5] Dehouck M.-P., Dehouck B., Fruchart J.-C., Ceccelli R., Sci. Tech. Technol. 23 (1993) 10-15.
6. [6] Miyake K., Kitaura F., Mizuno N., J. Chromatogr. 389 (1987) 47-56.
7. [7] Pidgeon Ch., Venkatarum V., Anal. Biochem. 176 (1989) 36-47.
8. [8] Thurnhofer H., Schnabel J., Betz M., Lipka G., Pidgeon Ch., Hauser H., Biochim Biophys. Acta 1064 (1991) 275-286.
9. [9] Pidgeon Ch., Ong S., Choi H., Liu H., Anal. Chem. 66 (1994) 2701-2709.
10. [10] Ong S., Liu H., Bhat G., Pidgeon Ch., Anal. Chem. 67 (1995) 755-762.
11. [11] Pidgeon Ch., Ong S., Liu H., Qiu X., Pidgeon M., Dantzig A.H., Munroe I., Hornback W.J., Kasher J.S., Glunz L., Czcerba T., J. Med. Chem. 38 (1995) 590-594.
12. [12] Pidgeon Ch., Ong S., Chem. Tech. (June 1995) 38-48.
13. [13] Kaliszan R., Nasal A., Bucinski A., Eur. J. Med. Chem. 29 (1994) 163-170.
14. [14] 'Substitued cyclopropylamino-1,3,5-triazines', EP 527117, 1992.
15. [15] '2-Amino-4-morpholino-6-propyl-1,3,5-triazines', EP 0 356 413 A1, 1989.
16. [16] van de Waterbeemd H., Kansy M., Chimia 46(7/8) (1992) 299-303.
17. [17] (a) Cho A.K., Haslett W.L., Jenden D.J., J. Pharmacol. Exp. Ther. 138 (1962) 249-257;
18. (b) Rathburn R.C., Slater I.H., Psychopharmacologia 4 (1963) 114-125.